[Fibrinolytic activity of brain tumors and treatment of hemorrhagic diathesis].
D000328:Adult; D007611:Aprotinin / Q000378:metabolism / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D002543:Cerebral Hemorrhage / Q000188:drug therapy; D002560:Cerebrovascular Circulation; D004789:Enzyme Activation; D005341:Fibrinolysin / Q000037:antagonists & inhibitors / Q000378:metabolism; D005342:Fibrinolysis; D005910:Glioma / Q000378:metabolism*; D006408:Hematoma, Subdural / Q000188:drug therapy; D006474:Hemorrhagic Disorders / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007223:Infant; D007705:Kinins / Q000378:metabolism; D008527:Medulloblastoma / Q000378:metabolism*; D008637:Mesenchymoma / Q000378:metabolism*; D010958:Plasminogen / Q000378:metabolism
D007705:Kinins; D010958:Plasminogen; D007611:Aprotinin; D005341:Fibrinolysin
Fibrinolytische Aktivität der Hirntumoren und Behandlung der Blutungsbereitschaft.